Weight and metabolic changes after switching from tenofovir alafenamide (TAF)/emtricitabine (FTC) +dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC + DTG, and TDF/FTC/efavirenz (EFV) to TDF/lamivudine (3TC)/DTG.
Bosch B, Akpomiemie G, Chandiwana N, et al. Clin Infect Dis. 2022;ciac949.
Chaudhary K, Patel MM, Mehta PJ. Crit Rev Ther Drug Carrier Syst. 2019;36(2):137-181.
First demonstration project of long-acting injectable antiretroviral therapy for persons with and without detectable human immunodeficiency virus (HIV) viremia in an urban HIV clinic.
Christopoulos KA, Grochowski J, Mayorga-Munoz F, et al. Clin Infect Dis. 2022; ciac631.
Cutrell J, Jodlowski T, Bedimo R. Ther Adv Infectious Dis. 2020;7:2049936120901395.
Duncan AD, Goff LM, Peters BS. PLoS One. 2018;13(3):e0194199.
Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.
Imbert E, Hickey MD, Clemenzi-Allen A, et al. AIDS. 2021;35(8).
Beyond core indicators of retention in HIV care: Missed clinic visits are independently associated with all-cause mortality.
Mugavero MJ, Westfall AO, Cole SR, et al. Clin Infect Dis. 2014;59(10):1471-1479.
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.
Neesgaard B, Greenberg L, Miró JM, et al. Lancet HIV. 2022;9(7):e474-e485.
Treatment adherence mediates the relationship between HIV-related stigma and health-related quality of life.
Onu DU. AIDS Care. 2021;33(10):1335-1339.
Palefsky JM, Lee JY, Jay N, et al. N Engl J Med. 2022;386(24):2273-2282.
Paton NI, Musaazi J, Kityo C, et al. N Engl J Med. 2021;385(4):330-341.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger AJ, Cambiano V, Bruun T, et al. Lancet. 2019;393(10189):2428-2438.
Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials.
Sax PE, Erlandson KM, Lake JE, et al. Clin Infect Dis. 2020;71(6):1380-1390.
Shafran SD, Hughes CA. HIV Med. 2023;24(3):361-365.